| BHEIX | MENRX | BHEIX / MENRX | |
| Total Expense Ratio | 0.80 | 0.90 | 89% |
| Annual Report Gross Expense Ratio | 0.89 | 0.90 | 99% |
| Fund Existence | 6 years | 14 years | - |
| Gain YTD | 11.527 | 3.301 | 349% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 500000 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.13B | 135M | 1,576% |
| Annual Yield % from dividends | 7.68 | 8.56 | 90% |
| Returns for 1 year | 21.18 | 6.95 | 305% |
| Returns for 3 years | 45.98 | 15.79 | 291% |
| Returns for 5 years | 59.97 | 30.96 | 194% |
| Returns for 10 years | N/A | 82.66 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MYCK | 24.63 | N/A | N/A |
| State Street® My2031 Corporate Bond ETF | |||
| FIXP | 19.87 | -0.03 | -0.14% |
| FolioBeyond Enhanced Fixed Inc Prm ETF | |||
| BUFD | 29.82 | -0.08 | -0.27% |
| FT Vest Laddered Deep Buffer ETF | |||
| JCE | 16.44 | -0.21 | -1.26% |
| Nuveen Core Equity Alpha Fund | |||
| MEMX | 46.36 | -1.68 | -3.50% |
| Matthews Emerging Markets Ex Chn Act ETF | |||